Utility of uroplakin II expression as a marker of urothelial carcinoma
Wei Tian(Johns Hopkins University), George J. Netto(University of Pennsylvania), Rajni Sharma(Central University of Punjab), Katayoon Rezaei(George Washington University), Justin A. Bishop(Johns Hopkins Hospital), Güneş Güner(Johns Hopkins University), Andrea P. Subhawong(Baptist Health South Florida), Nilda González-Roibón(Johns Hopkins University), Jonathan I. Epstein(Johns Hopkins University), Hiroshi Miyamoto(Tokushima University), Trinity J. Bivalacqua(University of Pennsylvania), Xuan Li(Johns Hopkins University), Ashley Cimino‐Mathews(Bloomberg (United States)), Pedram Argani(Johns Hopkins University)
Cited by 57
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
|New England Journal of Medicine|2005|3.1k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k